Extra ablation target may cut AF recurrence in persistent cases

NCT ID NCT06929897

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This trial tests whether adding posterior wall isolation to standard pulmonary vein isolation reduces atrial fibrillation recurrence in people with persistent AF. About 482 adults aged 20 to 80 will be randomly assigned to one of the two procedures using pulsed-field energy. Participants will be followed for 12 months to check for any return of abnormal heart rhythms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
pulmonary vein isolation with or without posterior wall isolation using pulsed-field ablation
What this could lead to
If successful, adding posterior wall isolation could become a standard approach to lower atrial fibrillation recurrence in patients with persistent AF.
What could go wrong
This is a single-center trial, and results may not apply to all patients. Adding extra ablation could increase complication risks without clear benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ewha Womans University Mokdong Hospitoal

    Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.